Genetic Pathways Leading to Fatty Liver and Atherogenic Dyslipidemia
Genetic Pathways Leading to Fatty Liver and Atherogenic Dyslipidemia
Enrolling by invitation · NCT04209816 · Registry updated 2023-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Genetic Pathways Leading to Fatty Liver and Atherogenic Dyslipidemia | Digestive System Diseases, Insulin Resistance, Nutritional and Metabolic Diseases, fatty liver disease, glucose metabolism disease, hyperinsulinism, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver disease | Enrolling by invitation | Not stated | 2023-09-22 | NCT04209816 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Göteborg University | 174 |
| Marja-Riitta Taskinen | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| RPU Clinical and Molecular Metabolism, Biomedicum | Helsinki | Finland | 1 |
| Wallenberg Laboratory | Gothenburg | Sweden | 1 |